I've posted a couple of times lately about recent advances in understanding and treating Alzheimer's disease. Now researchers at the University of Aberdeen in the UK and TauRx Therapeutics in Singapore have announced a new drug, called RemberTM, which dissolves the tangles of tau fibers which form inside nerve cells in the brain and destroy neurons critical for memory.
In the trials of people with mild-to-moderate Alzheimer's, patients given 60mg of Rember over 50 weeks showed an 81 percent reduction in mental decline. Over 19 months, patients on Rember showed no significant decline in mental function, while patients on the placebo grew steadily worse.
Additional, larger trials are planned and Rember could be available as early as 2012.